Blood test may flag heart danger before carotid surgery

NCT ID NCT05293067

Ongoing Knowledge-focused Sponsor: University of Belgrade Source: ClinicalTrials.gov ↗

First seen Jun 30, 2026 · Last updated Jul 01, 2026 · Updated 1 time

Summary

This trial investigates whether measuring high-sensitive troponin, a protein released during heart injury, can predict heart complications in people undergoing surgery to open a narrowed carotid artery. About 527 participants will have their troponin levels checked before and after the procedure. The goal is to see if this test can help doctors decide who is at higher risk and whether routine testing should be standard.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: high-sensitive troponin test
What this could lead to: If successful, this could help doctors identify which patients are at higher risk of heart problems after carotid surgery, potentially guiding safer treatment decisions.
What could go wrong: This is an observational study, not a treatment trial. It may not prove that troponin testing improves outcomes, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CAROTID ARTERY STENOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

carotid stenosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CAROTID ARTERY STENOSIS

Contacts and locations

Locations

Clinic for Vascular and Endovascular Surgery, University Clinical Center of Serbia

Belgrade, Serbia, 11000, Serbia

More trials for these conditions

Other studies related to the condition(s) this trial covers.